[{"Assets_0_Q3_USD":"1446700000.0","CIK":"899923","CommonStockSharesConverted_0_Q3_shares":"74500000.0","CommonStockSharesOutstanding_0_Q3_shares":"74500000.0","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"-1.55","EarningsPerShareBasic_3_Q3_USD":"-1.94","EarningsPerShareDiluted_1_Q3_USD":"-1.55","EarningsPerShareDiluted_3_Q3_USD":"-1.94","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","Market Cap":"1850258412.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"30700000.0","NetIncomeLossConverted_1_Q3_USD":"-115200000.0","NetIncomeLossConverted_3_Q3_USD":"-144100000.0","OfficialName":"Myriad Genetics Inc. Common Stock","RevenuesConverted_1_Q3_USD":"164000000.0","RevenuesConverted_3_Q3_USD":"545400000.0","SP500":null,"Sector":"Health Care","StockholdersEquityConverted_0_Q3_USD":"967200000.0","StockholdersEquity_0_Q3_USD":"967200000.0","Ticker":"MYGN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"74500000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"74200000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"74500000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"74200000.0","filed":"20200506","footnote":null,"form":"10-Q","fp":"Q3","fy":"2020.0","name":"MYRIAD GENETICS INC","period":"20200331","qtrs":"0","uom":"USD"}]